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Accurate and rapid diagnosis of malaria infections is crucial for implementing species-appropriate treat-
ment and saving lives. Molecular diagnostic tools are the most accurate and sensitive method of detecting
Plasmodium, differentiating between Plasmodium species, and detecting subclinical infections. Despite available
whole-genome sequence data for Plasmodium falciparum and P. vivax, the majority of PCR-based methods still
rely on the 18S rRNA gene targets. Historically, this gene has served as the best target for diagnostic assays.
However, it is limited in its ability to detect mixed infections in multiplex assay platforms without the use of
nested PCR. New diagnostic targets are needed. Ideal targets will be species specific, highly sensitive, and
amenable to both single-step and multiplex PCRs. We have mined the genomes of P. falciparum and P. vivax
to identify species-specific, repetitive sequences that serve as new PCR targets for the detection of malaria. We
show that these targets (Pvr47 and Pfr364) exist in 14 to 41 copies and are more sensitive than 18S rRNA when
utilized in a single-step PCR. Parasites are routinely detected at levels of 1 to 10 parasites/l. The reaction can
be multiplexed to detect both species in a single reaction. We have examined 7 P. falciparum strains and 91 P.
falciparum clinical isolates from Tanzania and 10 P. vivax strains and 96 P. vivax clinical isolates from
Venezuela, and we have verified a sensitivity and specificity of 100% for both targets compared with a nested
18S rRNA approach. We show that bioinformatics approaches can be successfully applied to identify novel
diagnostic targets and improve molecular methods for pathogen detection. These novel targets provide a
powerful alternative molecular diagnostic method for the detection of P. falciparum and P. vivax in conventional
or multiplex PCR platforms.
Malaria continues to be a leading cause of morbidity and
mortality worldwide. It is responsible for 200,000 to 300,000
diagnosed cases and 600,000 to 900,000 deaths in 2009 alone
(40). Early detection and accurate diagnosis are the best tools
for saving lives in regions of endemicity. Correct species iden-
tification and accurate diagnosis of mixed infections are of
particular importance for proper treatment in regions where
multiple parasite species are endemic. Of the five species
within the genus Plasmodium known to infect humans, Plas-
modium falciparum is the most deadly, followed by Plasmo-
dium vivax, which also causes significant morbidity and some
mortality (2, 10, 14, 23, 29, 38). P. falciparum and P. vivax also
have wider global distributions than other species. The remain-
ing three species (which are not the subject of this paper), P.
malariae, P. ovale, and P. knowlesi, have different global distri-
butions (with P. malariae being found primarily in South
America and Asia and P. ovale and P. knowlesi being found
primarily in Asia) and different levels of morbidity and mor-
tality.
Light microscopy remains the gold standard of malaria
diagnosis in regions of endemicity. While microscopy is cost-
effective and requires little equipment, a well-trained mi-
croscopist is essential. A highly trained and experienced
microscopist can typically detect parasitemias of as low as 90
to 200 parasites/l. Misdiagnosis may still occur due to low
parasitemia or mixed infection. Immunochromatographic
rapid diagnostic tests (RDTs) are increasingly being imple-
mented in case management and control programs. RDTs
identify the parasite antigens HRP2, pLDH, and pAldolase
and may be pan-specific (for all Plasmodium species), P.
falciparum specific, or both, depending on the test. RDTs
are not effective for the full diagnosis of mixed infections, as
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they can only distinguish P. falciparum and indicate the
presence or absence of another Plasmodium species. While
they can detect parasitemia at levels as low as 100 parasites/
l, they are not quantitative (21). Additionally, the HRP2
antigen can persist in blood after parasite clearance, leading
to false-positive diagnoses. It has also been reported that up
to 40% of P. falciparum parasites in some parts of South
America have HRP-2 gene deletions, increasing concerns
about false-negative diagnoses (8).
The use of molecular diagnostic tools is the most accurate
and sensitive method for detecting malaria parasite species.
Their current use, however, is restricted to reference labora-
tories or research studies, since there are limitations associated
with the use of molecular tools in regions of endemicity for
routine diagnostic use (including infrastructure problems, pro-
hibitive costs, a refrigerated or frozen supply cold chain, and
the requirement for trained personnel). Despite these limita-
tions, molecular methods are the best methods for detecting
multiple species and subclinical infections (4, 7), making them
invaluable for malaria parasite detection. Molecular methods
will become increasingly important given the proposed eradi-
cation/elimination goals and the need to detect subclinical
infections (12).
PCR-based amplification methods, including multiplex
PCR, real-time PCR, and, more recently, the loop-mediated
DNA amplification method (LAMP), have been developed to
detect malaria parasite species (11, 24, 25, 30, 31, 35, 37).
Molecular methods offer the advantage of highly specific dif-
ferentiation of Plasmodium species. Recently, molecular tech-
niques confirmed the natural infection of humans with the
zoonotic P. knowlesi in Southeast Asia (33). This simian ma-
laria parasite species had not previously been found in humans
in great numbers, and a similar morphology resulted in an
incorrect P. malariae diagnosis by microscopy.
The most widely used molecular target for the detection
of Plasmodium and diagnosis of malaria was developed prior
to the completion of any Plasmodium genome sequence.
The target is the 18S rRNA gene(s) (11, 16, 30, 32, 34). This
target was a logical choice given its high sequence conser-
vation, the availability of universal primer sequences for its
amplification, and the fact that it was known to exist in
multiple copies in all organisms that had been examined at
the time. The availability of complete Plasmodium genome
sequences presents a great opportunity for improving the
existing molecular diagnostic tools by identifying new tar-
gets for more sensitive and specific detection. The P. falcip-
arum genome was completed in 2002 (9), and P. vivax and P.
knowlesi have since been sequenced (5, 26). Despite the
existence of genomic information for three of the five hu-
man-infecting malaria parasites for many years, the majority
of molecular diagnostic tools still rely on 18S rRNA. Sub-
sequent examination of Plasmodium genome sequences has
revealed that the 18S rRNA target is present in only 4 to 8
divergent, nontandem copies, depending upon the species,
in contrast to the case for other eukaryotic genomes that
have hundreds of tandem copies of rRNA gene clusters (18,
19). In addition, the few 18S rRNA sequences that are
present are not identical in sequence and are variably ex-
pressed during the parasite life cycle (15). As PCR sensitiv-
ity is greatly influenced by the starting target molecule copy
number, a low target copy number limits the detection ca-
pabilities of these assays, especially if the parasitemia is low.
The 18S rRNA gene target also presents challenges for ef-
fective multiplex platforms. The design of multiple primers to
the same target can result in primer competition and decrease
the efficiency of the assay. While multiplex assays for simulta-
neous detection of malaria parasite species do exist (25, 31,
37), they show decreased sensitivity, particularly in detecting
the minor species (20). Rubio et al. (31) designed a seminested
two-tube multiplex PCR, with an initial genus-specific ampli-
fication followed by a secondary amplification using a universal
Plasmodium primer and species-specific reverse primers. Pad-
ley et al. (25) designed a one-tube multiplex assay, using spe-
cies-specific primers. However, both of these methods have
been shown to perform less effectively than the standard
nested PCR method (20). Taylor et al. (37) designed a multi-
plex real-time platform, relying on the increased sensitivity of
both novel targets and fluorescent probes. However, this assay
was most effective in duplex format and not as a true four-
species multiplex assay.
To address the limitations of existing molecular diagnostic
tools, we have mined Plasmodium genome sequence data and
identified new target DNA sequences for improved molecular
diagnostic applications. Here we detail the method used to
identify these targets in P. falciparum and P. vivax, and we show
that they provide increased sensitivity in a single-step PCR and
increased efficacy in multiplex assays.
MATERIALS AND METHODS
Data harvesting. Assembled genome sequence data for P. falciparum (3D7
strain) and P. vivax (Sal-1 strain) were obtained from PlasmoDB (release 5.5).
The P. falciparum genome data consist of 14 sequences (23,264,338 bp), and the
P. vivax genome data consist of 2,747 sequences (27,007,990 bp). Differences in
the numbers of sequences between species reflect the more advanced state of P.
falciparum genome assembly relative to P. vivax. There are 14 highly assembled
chromosomes for each species and 2,733 unassigned contigs for P. vivax.
CRS screens and copy number determination. The pipeline shown in Fig. 1
and described below was constructed using custom PERL scripts. Repeat-
Scout (version 1.0.5, default parameters) (28) was used to identify genomic
consensus repeat sequences (CRS). Totals of 418 P. falciparum and 428 P.
vivax CRS were generated. The Tandem Repeat Finder program (TRF)
version 4.0 (3) was used to eliminate CRS with internal tandem repeats that
could potentially interfere with PCR amplification. Repeats containing vector
sequences introduced during genome sequencing were identified by a com-
parison with the NCBI UniVec database (build 5.2; http://www.ncbi.nlm.nih
.gov/VecScreen/UniVec.html) (with WU-BLAST [blastn ver. 2.0; http://blast
.wustl.edu]) with an E-value cutoff of 1E10. To ensure that targets were not
also present in the human genome, CRS were compared to human genome
sequences (RefSeq, Primary Reference Assembly, build 37, version 1) with
BLAST (1) (version 2.2.22, blastn), with an E-value cutoff of 1E10. Screens
were applied in parallel to all CRS. Any sequence failing a screen was
removed from further consideration. A total of 165 P. falciparum sequences
and 331 P. vivax sequences passed all screens. All P. falciparum and P. vivax
CRS were compared (WU-BLAST) to all available Plasmodium sequence
data, and the results were manually inspected to ensure species specificity. To
allow sufficient space for primer design and the evaluation of repeat family
conservation, CRS smaller than 300 bp were not considered further. CRS
were used to calculate the copy number of each repeat. Each screened repeat
was used to search (WU-BLAST) against the species’ genome from which it
was derived. Repeat copies were required to hit to the CRS with an E value
of less than 1E50 for P. vivax. The stringency for P. falciparum was relaxed
to 1E10 because lower E-value requirements did not produce sufficient
candidates for screening. A minimum distance of 100 bp between copies was
required to remove potential amplification complications. Repeat families
with at least 6 copies were considered for further testing, yielding totals of 21
P. falciparum and 68 P. vivax candidates.
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Target validation. Primers were designed to test six P. falciparum and seven
P. vivax CRS families. Primers were designed manually to candidate targets
and screened for GC content, melting temperature, secondary structure, and
primer dimer-forming potential using Primer Explorer version 2.0 (http:
//primerexplorer.jp/e/). Primer pairs were optimized using gradient PCR cy-
cling on Bio-Rad iCycler machines to determine the optimum annealing
temperature, with additional adjustments to primer concentration (concen-
trations from 0.25 M to 1.0 M were tested) and master mix components
(MgCl2 concentrations from 2.0 mM to 4.0 mM were tested) (see below for
final conditions). Primers were further tested for species specificity using
laboratory cultures of P. falciparum (3D7) or DNA stocks of P. vivax (SV4),
P. malariae, P. ovale, and P. knowlesi.
Plasmodium parasites. P. falciparum strains 3D7, W2, V1-S, Dd2, HB3, D6,
and FCR3 were cultured in our laboratory. DNA stocks of P. vivax (Sal-1, SV4,
and NAM/CDC), P. ovale, P. malariae, and P. knowlesi and filter paper blood
spots of additional P. vivax strains (from Thailand, North Korea, Vietnam, India,
Miami [FL], New Guinea, South Vietnam, and Brazil) were all provided by John
Barnwell (CDC). DNA was isolated using commercially available QIAamp DNA
minikits (Qiagen, Valencia CA), following the manufacturer’s instructions.
Nested PCR. Nested PCR for malaria parasite detection (as described by
Singh et al. [32]) was used as the standard method for comparison.
Amplification of CRS targets by PCR. Amplification of CRS targets was
performed in a 25-l reaction mixture containing 1 Taq buffer (contains 10 mM
Tris-HCl, 50 mM KCl, and 1.5 mM MgCl2; New England BioLabs, Ipswich,
MA), 4 mM MgCl2, 200 M each deoxynucleoside triphosphate (dNTP), 500 nM
each oligonucleotide primer, 1.25 units of Taq DNA polymerase (New England
BioLabs), and 1 l of DNA template. Oligonucleotide primers for P. falciparum
candidate Pfr364 and P. vivax candidate Pvr47 are shown in Table 1. Separate
reactions were performed for P. falciparum and P. vivax with the following cycling
parameters: initial denaturation at 95°C for 2 min and then 35 cycles of 95°C for
30 s, 57°C (for P. falciparum) or 54°C (for P. vivax) for 30 s, and 72°C for 45 s,
followed by final extension at 72°C for 5 min. PCR products were visualized by
gel electrophoresis on a 2% agarose gel.
Serial dilutions of quantified parasite DNA, isolated from laboratory cul-
tures, were used to determine the detection limits (DNA concentrations
ranging from 10,000 parasites/l to 0.01 parasites/l were tested). Final
validation of targets was performed with P. falciparum and P. vivax clinical
samples from Tanzania (n  91; median parasitemia, 3,200 parasites/l) and
Venezuela (n  96; no parasitemia data are available), respectively, as well as
with additional geographically diverse strains for both targets (for Pfr364, P.
falciparum strains W2, V1-S, Dd2, HB3, D6, and FCR3; for Pvr47, P. vivax
isolates from Thailand, North Korea, Vietnam, India, Miami, New Guinea,
South Vietnam, and Brazil).
Multiplex PCR. The multiplex PCR platform was optimized by gradient PCR
cycling to determine the annealing temperature, with additional adjustments to
primer concentrations (0.25 to 1.0 M were tested) and master mix component
concentrations (MgCl2 from 2.0 mM to 4.0 mM, dNTPs from 200 M to 400 M
each, and Taq DNA polymerase from 1.25 units to 2.5 units were all tested).
Multiplex PCR for detecting P. falciparum and P. vivax was performed in a 25-l
reaction mixture containing 1 Taq buffer (New England BioLabs, Ipswich MA;
contains 10 mM Tris-HCl, 50 mM KCl, and 1.5 mM MgCl2), 4 mM MgCl2, 400
M each dNTP, 1,000 nM each P. falciparum primer, 600 to 800 nM each P. vivax
primer, 2.5 units of Taq DNA polymerase (New England BioLabs, Ipswich, MA),
and 1 l of DNA template. The alternate P. falciparum oligonucleotide primer
sequences (Table 1) were used in the multiplex assay. The P. vivax primers were
the same as used in the conventional PCR described above. The reaction was
carried out under the following cycling parameters: initial denaturation at 95°C
for 2 min and then 35 cycles of 95°C for 30 s, 60°C for 30 s, and 72°C for 45 s,
followed by final extension at 72°C for 5 min. All possible combinations of
10-fold dilutions ranging from 10,000 parasites/l to 0.01 parasites/l for each
species were tested. PCR products were visualized by gel electrophoresis on a 2%
agarose gel.
Sensitivity and specificity calculations. Sensitivity and specificity (95% confi-
dence interval) were calculated using the nested 18S rRNA PCR as the gold
standard for distinguishing a true positive from a false positive (Table 2).
FIG. 1. Schematic of diagnostic target screening and development
pipeline. All genomic sequences for P. vivax and P. falciparum were
downloaded from PlasmoDB. Data were mined for repeats using the
RepeatScout algorithm to construct consensus repeat sequences
(CRS) for each identified repeat family. CRS were then screened in
parallel for tandem repeats, similarity to human sequences, and vector
sequences. Any CRS failing these screens were removed from further
consideration. CRS that were not species specific or less than 300 bp
long were eliminated. Family copy numbers for the remaining candi-
dates were determined via comparison of the CRS against the appro-
priate genome data. Candidate repeat families containing 6 or more
copies separated by at least 100 bp were considered for further testing.
For additional information and clinical sample validation, see Materi-
als and Methods.
TABLE 1. New target primer sequencesa
Primer
Sequence





a Primer sequences designed to targets Pfr364 and Pvr47. The alternate (Alt) primer pair for P. falciparum was used in multiplex reactions only. The P. vivax primer
set was the same for both single-species and multiplex PCRs.
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RESULTS
Repeat mining and screening of diagnostic candidates. A
semiautomated bioinformatics pipeline was constructed for ge-
nome repeat mining and in silico candidate screening (Fig. 1)
(see Materials and Methods). Six P. falciparum and seven P.
vivax putative targets were identified for validation. Over 50
primer pairs were designed to these targets and empirically
tested in conventional PCR amplification assays and multiplex
assays. Of these targets, the most effective were P. falciparum
candidate Pfr364 and P. vivax candidate Pvr47, as these targets
consistently performed with the greatest sensitivity and speci-
ficity. The functions of Pfr364 and Pvr47 are not known. Nei-
ther sequence is annotated or encodes protein. However,
regions of Pfr364 are expressed according to PlasmoDB. Full-
length sequence alignments and repeat coordinates can be
found in Fig. S1 and S2 and Table S1 in the supplemental
material.
Diagnostic targets: copy number and distribution. At least
one putative target from each species was found to significantly
improve existing diagnostic capabilities. Pfr364 exists in 41
copies, each of which is localized to the SB2 subtelomeric
repeat region found on most chromosome ends (Fig. 2). The
size of the SB2 region of P. falciparum chromosomes is variable
(1 to 3 kb, though it may contain up to 6 kb of additional
sequence) and is composed of different repeat types (9). Many
regions were found to contain two proximal copies of Pfr364,
and chromosome 6 contains three copies at its 3 end (data not
shown). Multiple alignment reveals significant subfamily struc-
ture resulting in two related alignment groups, which we have
designated subfamilies 1 and 2 (Fig. 3A; see Fig. S2 and Table
S1 in the supplemental material). Interestingly, when multiple
copies of Pfr364 are found at chromosome ends, there is one
member of each subfamily present (Fig. 2).
Pvr47 is found in 14 copies (Fig. 3B; see Fig. S1 and Table S1
in the supplemental material). All members are located on
contigs that have not yet been assigned to chromosome scaf-
folds. The majority of these members map to small (16-kb)
subtelomeric contigs that could not be assembled onto chro-
mosomes due to their repetitive nature (5). Two of these family
members are located proximal to annotated vir genes, while a
third is located proximal to the subtelomeric transmembrane
protein Pvstp1 (6).
Detection of P. vivax and P. falciparum. Primers designed to
Pfr364 and Pvr47 (Table 1) specifically identified P. falciparum
and P. vivax, respectively. Other Plasmodium species, including
P. malariae, P. ovale, and P. knowlesi, were not amplified. No
amplification was observed using human nonmalaria DNA
(data not shown). Using known quantities of laboratory-cul-
tured parasites, we were able to consistently detect parasites in
concentrations of as low as 10 to 0.1 parasites/l, compared to
10 to 1 parasites/l detected with the standard method (Fig. 4
and Table 3). P. falciparum candidate Pfr364 detected between
10 and 0.1 parasites/l of DNA (detected 0.1 parasites/l twice
and 10 parasites/l once). For each repeat target, single am-
plified products were clearly defined on a 2% agarose gel
stained with ethidium bromide.
Specificity and sensitivity. The targets were further vali-
dated in three ways. First, microscopically determined P. vivax
samples from Venezuela (n  96) and P. falciparum samples
from Tanzania (n  91) were used. In comparison to standard
nested 18S rRNA PCR, Pvr47 had 98.9% sensitivity and 100%
specificity, and Pfr364 had 100% sensitivity and 100% speci-
ficity. Second, target amplification in 7 P. falciparum strains
and 10 P. vivax strains from around the world was assessed.
The target was successfully amplified in each case (Fig. 5).
Finally, PlasmoDB was queried to assess the number and dis-
tribution of single-nucleotide polymorphisms (SNPs) in the 41
P. falciparum repeats using data reported previously (13, 22,
39). These data represent information from 21 P. falciparum
strains. There are an average of 50 polymorphic sites along the
1,500-nucleotide (nt) length of each of the Pfr364 repeats,
FIG. 2. Spatial distribution of Pfr364 family members across the 14
P. falciparum chromosomes. Tick marks indicate 200 kb of sequence.
Pfr364 family members occur in two proximal copies at most chromo-
some ends. Black lines represent the outermost copies (subfamily 1),
and gray lines represent the innermost copies (subfamily 2). Chromo-
some 6 has three copies at its 3 end (only two are shown). Circos 0.51
(http://mkweb.bcgsc.ca/circos/) was used to generate this map.
TABLE 2. Sensitivities and specificities of new PCR assays















P. falciparum Positive (91) 91 0 100 100
Negative (9) 0 9
P. vivax Positive (96) 95 1 98.9 100
Negative (13) 0 13
a The sensitivities and specificities of the new PCR assays were compared to
those of standard nested 18S rRNA PCR (32). For conventional PCR, sensitivity
and specificity were calculated using 96 P. vivax samples from Venezuela and 91
P. falciparum samples from Tanzania. DNA from nonmalarious patients was
included as a negative control.
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for an average of 3% each. An average of 2 different nucleo-
tides are observed at each polymorphic position (see Table S2
in the supplemental material).
Multiplex assay. The multiplex PCR assay with combined
Pvr47 and Pfr364 specifically detected P. vivax and P. falcipa-
rum and correctly identified both single- and mixed-species
infections. An alternative P. falciparum primer was used to
make the PCR products similar in size to increase efficiency
(see Materials and Methods) (Table 1). The limit of detection
for the multiplex platform was determined using “mock mixed”
infections of P. falciparum and P. vivax laboratory cultures.
This method had a limit of detection of 10 parasites/l for each
species (Fig. 6). P. falciparum DNA was also detected at 1.0
parasites/l when P. vivax was present at the same concentra-
tion (P. vivax was not detected). Clinical mixed P. falciparum-P.
vivax samples from Venezuela (n  11) were detected with
90.9% sensitivity and 100% specificity in comparison to the
standard nested PCR method, which was performed as sepa-
rate reactions for the different species.
DISCUSSION
Here we show the value of applying bioinformatics methods
and mining genomic data to answer biological questions that
address practical needs. This approach can be applied to ad-
ditional pathogens or used to improve existing molecular di-
agnostic tools (LAMP, real-time PCR, etc.). Increasing the
sensitivity and specificity of molecular assays will facilitate
greater high-throughput detection of pathogens.
Discovery of the exact locations of Pvr47 repeats will depend
on the continued refinement of the P. vivax genome assembly
and improved annotation. The presence of some members
near genes known to be located in subtelomeric regions (see
above), combined with the known subtelomeric location of
Pfr364, points to an interesting role in Plasmodium chromo-
some end biology for use in diagnostic target development.
There has been no comprehensive, systematic study of the
genomic repeats of the genus Plasmodium. Our understanding
of the organization and content of subtelomeric regions is
FIG. 3. Alignments of Pfr364 and Pvr47 family members with PCR primers. (A) Pfr364 with primers. Arrows represent locations of PCR
primers in context of the full alignment. The full alignment is 1,538 positions in length; here a partial alignment is shown. Vertical black lines
indicate where the sequence alignment has been truncated to enable viewing of all 4 primer locations. The alignment shows two subfamilies within
Pfr364. We have designated the upper 22 sequences subfamily 1 and the lower 19 sequences subfamily 2. Forward and reverse primer pairs used
for multiplex and conventional PCR are, respectively, the last two sequence pairs in the alignment. (B) Pvr47 with primers. Arrows represent
locations of PCR primers in context of the full alignment. The full alignment is 1,070 positions; here only positions 433 to 776 are shown. Vertical
lines indicate where the sequence alignment has been truncated for easier viewing. Forward and reverse primers are, respectively, the last two
sequences in the alignment.
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largely restricted to what is known in P. falciparum, where it
has been shown that these regions contain genes responsible
for host immune evasion and antigenic variation (9). Given the
biological importance of these regions and the useful diagnos-
tic targets that they contain, it is critical that we increase our
understanding of their repeat content and organization.
While there is evidence for their location and distribution,
the biological functions of Pfr364 and Pvr47 are not yet estab-
lished. Combined with their repetitive, potentially nongenic
nature, this necessitates a thorough evaluation of their robust-
ness as diagnostic targets. Sequences with no coding potential
often evolve more quickly than coding regions (17). However,
we show that these families are highly conserved (3% varia-
tion at the nucleotide level in P. falciparum), which is indicative
of selection. Further, assays designed to the targets were able
to detect infections across as large a range of field isolates (7 P.
falciparum strains and 10 P. vivax strains) as the standard
nested 18S rRNA PCR. These observations suggest that these
targets are as robust to evolutionary change as the 18S rRNA
target, despite the uncertainty about their biological roles.
Pfr364 and Pvr47 are not necessarily the most abundant
repeats in these genomes. We tested only a few repetitive
sequences resulting from our data mining for their potential as
diagnostic targets. It is possible that more sensitive targets
exist. As we have noted above, there has been no comprehen-
FIG. 4. Limits of detection for conventional PCR assays. Primers
to novel targets P. falciparum Pfr364 (A) and P. vivax Pvr47 (B) were
used to amplify parasite DNA of the appropriate species. DNA was
quantified, and 10-fold serial dilutions from 10,000 parasites/l (lane
1) to 0.01 parasites/l (lane 7) were used to determine the limit of
detection. A 100-bp standard ladder (L) and a no-template control
(NTC) were included.
TABLE 3. Detection limits of new diagnostic targets
Replicate
Detection limit (parasites/l)a




a Calculated using 10-fold serial dilutions of P. falciparum and P. vivax DNAs
(see Fig. 4).
FIG. 5. Evaluation of Pfr364 and Pvr47 primers on geographically
diverse field isolates. (A) Pfr364 primers tested on various P. falcipa-
rum isolates. Lanes: 1, 3D7; 2, W2; 3, V1-S; 4, Dd2; 5, Hb3; 6, D6; 7,
FCR3. A 100-bp standard ladder (L) and a no-template control
(N) were included. (B) Pvr47 primers tested on various P. vivax field
isolates. Lanes: 1, Thailand; 2, North Korea; 3,Vietnam; 4, India; 5,
NAM/CDC; 6, Miami; 7, New Guinea; 8, Sal-1; 9, South Vietnam; 10,
Brazil. The Pfr364 and Pvr47 primers clearly detect all of the tested
isolates. Pfr364 primers detected an additional 91/91 (100%) P. falcip-
arum isolates from Tanzania, and Pvr47 primers detected an additional
95/96 (98.9%) P. vivax isolates from Venezuela (not shown).
FIG. 6. Multiplex PCR. The multiplex method clearly identified
mock mixed P. falciparum and P. vivax infections (lane Pf/Pv). Single-
species infections (lanes Pf and Pv) were also detected. The P. falcip-
arum band appears at 220 bp and the P. vivax band at 333 bp. A 100-bp
standard ladder (L) and a no-template control (NTC) were used.
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sive investigation of the genomic repeat content of these or-
ganisms, and our analysis is ongoing.
Amplification of the novel targets presented here was highly
sensitive and specific. Both assays have a detection limit 10-
fold lower than the historic standard and utilize a single, as
opposed to nested, PCR. This is an important improvement, as
single-round, unnested PCRs have fewer steps, decrease the
chances of contamination or error, decrease the overall cost in
materials, and require less time to complete. The standard
nested protocol requires two separate reactions, and the am-
plified product of the first reaction must be transferred to a
second tube prior to the second reaction. Opening the tubes
increases the risks of contamination and human error and also
increases the time and costs for necessary reagents and con-
sumables.
The targets produced clean products, clearly visible on an
agarose gel stained with ethidium bromide, at 716 bp and 333
bp for P. falciparum and P. vivax, respectively. There were no
nonspecific bands in clinical samples, including negative sam-
ples, as was sometimes found with the standard PCR method
(data not shown). While DNA amplified from laboratory cul-
tures using the standard nested PCR method showed clean
bands on the agarose gel, clinical samples often produced
nonspecific bands with sizes similar to those of the expected
bands when the 18S rRNA gene-based method was used. This
can be especially confusing when interpreting the results, and
additional time was required to fully separate the bands by
electrophoresis. The nonspecific bands appeared when P. fal-
ciparum samples were tested to amplify field samples with the
P. vivax-specific primers (unpublished observation). Addition-
ally, sometimes several rounds of repetition of the standard
method described by Singh et al. (32) were necessary to con-
firm the results for the clinical samples tested. We found that
PCR amplification with the newly identified targets yielded
consistent clear results with no spurious bands among the
clinical samples tested in this study.
One-step multiplex reactions will offer a great improvement
to existing Plasmodium diagnostics. Efficient, high-throughput
pathogen detection will decrease the time to results and ap-
propriate treatment. Mixed infections naturally occur in re-
gions where multiple parasite species are found, and these
present a challenge for diagnosis. To validate our multiplex
method, we tested all possible combinations of 10-fold DNA
concentrations (from 10,000 parasites/l to 1 parasite/l) to
cover all the range of naturally occurring mixed infections
(data not shown). The limit of detection (10 parasites/l for P.
falciparum and P. vivax) compares favorably to those for other
multiplex methods. In mixed-species infections, one major spe-
cies will frequently dominate over another that is present in
relatively low concentrations during PCR amplification (27,
36). In contrast, the current method detects both major and
minor species of mixed infection, providing another advantage
of using this method for diagnosis.
In conclusion, the findings from this study demonstrate that
using bioinformatics to identify novel genetic targets for diag-
nostic application is a valid approach. This methodology will be
extended to identify additional targets from other Plasmodium
species for diagnostic assays when the genome sequences be-
come available. Our results demonstrate that the newly iden-
tified Pfr364 and Pvr47 targets are valuable tools to improve
and simplify molecular diagnostic methods for field use.
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